. 2012 Sep-Oct;5(6):379–386.

Table 4.

Generalized Linear Models Regression Analysis for Adjusted Mean Medical Costs: Outpatient plus Inpatient/Emergency Department

Medication-specific medical costs	Mean adjusted medical costs, $ (outpatient + inpatient/emergency department)	95% Confidence interval
Medication-specific medical costs		Lower costs, $	Upper costs, $
All-cause costs
Aripiprazole	911	866	958
Olanzapine	1100^a	1039	1165
Quetiapine	1221^a	1180	1263
Risperidone	1040^a	984	1099
Ziprasidone	1216^a	1126	1312
Mental health–related costs
Aripiprazole	576	543	610
Olanzapine	714^a	668	762
Quetiapine	804^a	773	836
Risperidone	757^a	711	807
Ziprasidone	823^a	754	898

P <.05 versus aripiprazole.

Costs reported as per treated patient per month in 2008 US dollars. Estimates are reported after controlling for age, sex, year of index prescription, Charlson comorbidity index, diabetes, hyperlipidemia, glucose and lipid testing, baseline hospitalization rate, and use of mood stabilizers.